CYTOSORBENTS MEDICAL INC
Federal contract awards won by CYTOSORBENTS MEDICAL INC (UEI LSF2KFUSY4K7), 2019–2022 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
5
awards
1
expiring in 12 months
1
agency
Agencies buying from CYTOSORBENTS MEDICAL INC
What CYTOSORBENTS MEDICAL INC has provided
Awards
AWARD OF CYTOSORBENTS DHA SBIR PH III MED R&D CONTRACT FOR "INTEGRATING ISOAGGLUTININ REDUCTION FOR A UNIVERSAL DRIED PLASMA PRODUCT FOR BATTLEFIELD AND FIRST RESPONDER USE"
Department of Defense · $4,292,641 · Aug 22, 2022
MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR SEQUENTIAL PH II PROPOSAL NO. H2S-0011 TITLED INVESTIGATION OF A POTASSIUM ADSORBER FOR THE TREATMENT OF HYPERKALEMIA INDUCED BY TRAUMATIC INJURY AND ACUTE KIDNEY INJURY IN AUSTERE MEDICINE.
Department of Defense · $1,499,987 · Apr 21, 2021
MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PHASE II PROPOSAL NO. H2S-0005 TITLED DEVELOPMENT OF AN EFFECTIVE ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM PLASMA FOR TRANSFUSION.
Department of Defense · $1,098,589 · Sep 24, 2020
AWARD OF CYTOSORBENTS' DHA STTR RIF PHASE III MEDICAL R&D CONTRACT FROM PROPOSAL DHP15B-001-P-6144 FOR "DEVELOPMENT OF A HIGHLY EFFICIENT ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM BLOOD AND PLASMA FOR TRANSFUSION"
Department of Defense · $2,897,172 · Jun 15, 2020
K+ONTROL RENAL SUPPORT SYSTEM FOR REDUCTION OF HYPERKALEMIA - RIF
Department of Defense · $2,959,747 · Sep 24, 2019